SCHEMBL10139237

SCHEMBL10139237

CCOC(=O)c1cnc2cc(F)c(N3CCOCC3)cc2c1N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
KDM4E B2RXH2 2/20 0.54
HSD17B10 Q99714 2/20 0.54
HPGD P15428 1/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
MAPT P10636 7/20 0.49
GAA P10253 6/20 0.49
L3MBTL1 Q9Y468 4/20 0.49
HTT P42858 3/20 0.49
LMNA P02545 2/20 0.49
MC4R P32245 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
PTK2B Q14289 1/20 0.49
MAPK1 P28482 2/20 0.48
CLK1 P49759 1/20 0.48
GSK3A P49840 1/20 0.48
GSK3B P49841 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL538179 0.89 HSD17B10 (0.55) ALDH1A1KDM4EHSD17B10HPGDMEN1
SCHEMBL538231 0.88 ALDH1A1 (0.54) ALDH1A1KDM4EHSD17B10HPGDMEN1
SCHEMBL2904843 0.80 CSF1R (0.63) MEN1KMT2AMAPTGAAL3MBTL1
SCHEMBL12143424 0.75 ALOX15 (0.57) ALDH1A1KDM4EHSD17B10HPGDMEN1
SCHEMBL23701351 0.74 MEN1 (0.56) ALDH1A1KDM4EHSD17B10HPGDMEN1
SCHEMBL2912835 0.74 KCNH2 (0.63) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL2912345 0.74 CSF1R (0.71) MEN1KMT2AMAPTGAAL3MBTL1
SCHEMBL22717265 0.73 PKM (0.55) ALDH1A1KDM4EHSD17B10HPGDMEN1
SCHEMBL12844576 0.73 ALOX15 (0.53) ALDH1A1KDM4EHSD17B10HPGDMEN1
SCHEMBL16235611 0.73 PIK3CA (0.60) ALDH1A1KDM4EHSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2166852-B1 THERAPEUTIC PYRAZOLOQUINOLINE DERIVATIVES HELICON THERAPEUTICS INC (US) 2012-02-08 EP disclosed